According to the latest report by IMARC Group, titled "High-performance Liquid Chromatography (HPLC) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global high-performance liquid chromatography (HPLC) market reached a value of US$ 5.1 Billion in 2021. High performance liquid chromatography (HPLC) refers to a chromatographic technique that is widely employed to separate, identify and quantitate different components in the given mixture. It involves the passing of the solvent comprising the sample mixture through a column containing adsorbent material with the help of a pressure pump. Since the components present in the sample react differently with the adsorbent material, it results in dissimilar flow rates of the various constituents, thereby separating the mixtures in an efficient manner. Consequently, it is extensively used across various sectors for trace analysis, disease diagnosis, food quality control and drug development.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global High-performance Liquid Chromatography (HPLC) Market Trends:
The global market is majorly driven by considerable growth in the pharmaceutical sector. Since HPLC is increasingly used for quality control, analysis of drug samples, manufacturing complex pharmaceutical drugs, purification of monoclonal antibodies and obtaining faster and precise compound separation results, this is expected to provide a thrust to the market growth. The market is further driven by the escalating adoption of HPLC tests in drug approvals and the rising investments in academics and life sciences segments across the globe. Moreover, continual advancements in the column and pump technologies have contributed to high-quality analysis that yields accurate results in lesser time while withstanding high pressure from smaller, superficially porous particles. Numerous players are also investing in the development of automated, portable and computerized HPLC devices to offer enhanced convenience to the users. This, along with the extensive research and development (R&D) activities in life sciences, is anticipated to positively impact the market growth. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 6.8 Billion by 2027, growing at a CAGR of 4.86% during 2022-2027.
- On the basis of the product, the market has been divided into instruments [HPLC systems (automated and manual), detectors, pumps, and others], consumables (columns, tubes, vials, filters, and others), and accessories.
- Based on the application, the market has been classified into clinical research, diagnostics, forensic, and others.
- On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
- The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Agilent Technologies Inc., Bio-RAD Laboratories Inc., Gilson Inc., Hitachi Ltd., Perkinelmer Inc., Phenomenex Inc. (Danaher Corporation), Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation, and Waters Corporation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800